Skip to main content

Beatriz Minguez Rosique

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Beatriz Minguez Rosique

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Related news

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Related professionals

Laura Blasco Perez

Laura Blasco Perez

Research technician
Genetics Medicine
Read more
Sergio Aguilar Alegre

Sergio Aguilar Alegre

Read more
Eugènia Serramontmany Morante

Eugènia Serramontmany Morante

Read more
Maria Belén Viñado Perez

Maria Belén Viñado Perez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.